galluzzo, alessandro
 Distribuzione geografica
Continente #
NA - Nord America 830
EU - Europa 386
AS - Asia 156
SA - Sud America 2
AF - Africa 1
Totale 1.375
Nazione #
US - Stati Uniti d'America 827
CN - Cina 130
DE - Germania 130
UA - Ucraina 80
GB - Regno Unito 45
IT - Italia 44
RU - Federazione Russa 25
FI - Finlandia 23
IE - Irlanda 17
HK - Hong Kong 16
FR - Francia 11
BE - Belgio 7
IN - India 5
CA - Canada 3
PK - Pakistan 2
AR - Argentina 1
BD - Bangladesh 1
BR - Brasile 1
JP - Giappone 1
MU - Mauritius 1
NL - Olanda 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.375
Città #
Chandler 105
Fairfield 87
Ashburn 85
Jacksonville 70
New York 60
Ann Arbor 58
Woodbridge 47
Houston 46
Seattle 35
Princeton 34
Cambridge 33
Wilmington 25
Beijing 21
Helsinki 21
Nanjing 20
Dublin 17
Hong Kong 16
Dearborn 15
Lancaster 15
Nanchang 15
Brescia 12
Shenyang 11
Des Moines 10
Changsha 9
Tianjin 8
Brussels 7
Jinan 7
Washington 7
Castiglione delle Stiviere 6
Hebei 6
Nürnberg 5
Taiyuan 4
Zhengzhou 4
Hangzhou 3
Kunming 3
Lanzhou 3
London 3
Ningbo 3
Boardman 2
Bordighera 2
Flero 2
Hefei 2
Multan 2
Pioltello 2
San Diego 2
San Francisco 2
Shanghai 2
Southwark 2
Taizhou 2
Toronto 2
Amsterdam 1
Bratislava 1
Buenos Aires 1
Cerea 1
Changchun 1
Chengdu 1
Chiswick 1
Chongqing 1
Cologno Monzese 1
Dhaka 1
Guangzhou 1
Jiaxing 1
Leawood 1
Lipomo 1
Lisbon 1
Milan 1
Nardò 1
Nogara 1
North York 1
Norwalk 1
Orange 1
Redwood City 1
Riyadh 1
Rome 1
San Mateo 1
Serra D'aiello 1
São Paulo 1
Tokyo 1
Torino 1
Toussieu 1
Whyteleafe 1
Totale 991
Nome #
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 127
Comparison of quetiapine, olanzapine and risperidone in schizophrenia. 110
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study 107
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 105
Comparison of Quetiapine, Olanzapine, and Risperidone in Patients With Schizophrenia: Interim Results of a Randomised, Rater-blinded Study. 103
The role of the cytochine network in schizophrenia: an overview. 103
Interim results of a randomised, rater-blinded study comparing quetiapine, olanzapine and risperidone in patients with schizophrenia. 99
Comparison of quetiapine (‘Seroquel’), olanzapine and risperidone in a randomized study in patients with schizophrenia. 98
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 93
Comparison of quetiapine, olanzapine and risperidone in a randomized study in patients with schizophrenia. 75
Relationship of IQ to neuropsychological tasks involving prefrontal cortex in schizophrenia. 74
The factor structure analysis for the positive and negative syndrome scale (PANSS) in pharmacogenetics and pharmacogenomics studies. 72
Implementing cognitive rehabilitation interventions for schizophrenia patients in mental health services: Focus on Integrated Psychological Therapy (IPT) 56
The complex relationship between self-reported 'personal recovery' and clinical recovery in schizophrenia 49
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 47
Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives 43
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 41
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 21
Totale 1.423
Categoria #
all - tutte 5.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.978


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201971 0 0 0 0 0 0 0 0 0 13 29 29
2019/2020331 46 8 10 27 15 47 29 36 26 40 33 14
2020/2021200 3 21 4 16 3 18 9 26 25 42 24 9
2021/2022119 15 13 0 12 0 6 1 8 5 12 12 35
2022/2023250 20 3 5 34 16 61 3 26 52 2 14 14
2023/2024188 10 2 23 22 19 83 0 3 22 4 0 0
Totale 1.423